Projection-Domain SPECT Quantification for Ultra-Low Photon Counts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying the dose of alpha particle-emitting radiopharmaceutical therapies (αRPTs) are inaccurate and imprecise due to low photon counts, leading to non-optimal therapies and challenges in personalizing treatment regimens, especially in low-count single-photon emission computed tomography (SPECT) imaging.
Innovation Solution
A system and method for low-count quantitative SPECT (LC-QSPECT) that uses a computer device to model a system matrix based on CT scans, adjust for stray-radiation noise, and detect photons emitted by alpha-particle-emitting isotopes to determine source volumes of interest directly from projection data, incorporating multiple energy windows for improved data analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional SPECT imaging methods are used for alpha-particle-emitting radiopharmaceutical therapies, then the imaging system can detect photons, but the measurement precision and quantification accuracy deteriorate due to ultra-low photon counts (up to 3 orders of magnitude lower than diagnostic SPECT)
Solution Approach 1:
The system performs preliminary actions by acquiring high-quality CT scans before SPECT imaging to create accurate attenuation maps and system matrices. The CT-based attenuation correction and system matrix modeling are performed in advance to compensate for the low photon counts during the actual SPECT acquisition, enabling accurate quantification despite ultra-low counts
Solution Approach 2:
The patent replaces conventional image reconstruction-based quantification methods with a direct projection-domain quantification approach. Instead of reconstructing images and then measuring activity, the system directly solves for activity distribution in the projection domain using CT-derived attenuation maps and system matrices, which is more accurate for low-count scenarios
2Manufacturing precision
If conventional image reconstruction methods are used for low-count SPECT, then the imaging process can be completed, but the manufacturing precision and quantification accuracy deteriorate due to noise amplification and poor convergence at low counts
Solution Approach 1:
The quantification process is segmented into distinct steps: CT-based attenuation map generation, system matrix modeling using CT data, projection data acquisition, and direct solution of activity distribution. This segmentation allows each component to be optimized independently, with the CT-based attenuation correction and system matrix modeling specifically addressing the low-count challenges
Solution Approach 2:
The patent introduces CT-based attenuation maps and system matrices as intermediary elements that mediate between the raw projection data and the final activity quantification. These intermediaries, derived from high-quality CT scans, provide the necessary correction factors and probability models to achieve accurate quantification despite low photon counts
3Adaptability or versatility
If personalized treatment regimens are desired for alpha-particle-emitting radiopharmaceutical therapies, then treatment optimization can be achieved, but the measurement accuracy deteriorates because existing methods cannot provide reliable dose quantification at ultra-low counts
Solution Approach 1:
The system enables feedback-based personalized treatment by providing accurate quantitative SPECT images that reflect the actual biodistribution of the radiopharmaceutical. This feedback information on actual uptake and dose distribution allows clinicians to adjust subsequent treatment cycles to optimize therapy outcomes and minimize toxicity,实现真正的个性化治疗
Solution Approach 2:
The patent changes the fundamental parameters of the quantification approach by using CT-based attenuation correction and system matrix modeling instead of conventional methods. This parameter change in the quantification methodology enables accurate dose measurement at ultra-low counts, making personalized treatment regimens feasible
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The LC-QSPECT method provides accurate and precise quantification of absorbed doses in organs and tumors, enabling personalized treatment regimens and effective monitoring of therapy outcomes and adverse events.
Implementation Method 1
one or more sensors configured for detecting one or more emitted photons
Data Source
AI summary
A system for low-count quantitative single-photon emission computed tomography (LC-QSPECT) is provided. The system is programmed to a) store a computer tomography (CT) scan of a subject being examining including a plurality of defined volumes of interest (VOIs) of the subject being examined; b) model a system matrix based on the stored CT, wherein the model describes the probability that photons emitted from each of the defined VOIs are detected in different projection bins, wherein a plurality of projection bins are defined around the subject and the defined VOIs; c) adjust the model with analysis of stray-radiation noise around the subject; d) detect, by the one or more sensors, one or more photons being emitted by an alpha-particle-emitting isotope; and e) execute the adjusted model with the one or more detected photons as inputs to determine a source VOI of the detected photons.